Clinical application of red cell distribution width, mean platelet volume, and cancer antigen 125 detection in endometrial cancer. Issue 8 (20th March 2020)

• Record Type: Journal Article
• Authors: Zhang, Hongyu; Liang, Ka; Ke, Liuhua; Tang, Shifu
• Is Part Of: Journal of clinical laboratory analysis. Volume 34:Issue 8(2020)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-03-20
• Subjects: cancer antigen 125 -- endometrial cancer -- endometrial hyperplasia -- mean platelet volume -- red cell distribution width; Diagnosis, Laboratory -- Periodicals; Medical laboratory technology -- Periodicals; 616
• DOI: 10.1002/jcla.23309
• Languages: English
• ISSNs: 0887-8013

Abstract

Abstract: Background: Red cell distribution width (RDW) and mean platelet volume (MPV) are considered to be associated with tumors. We investigated the diagnostic value of RDW, MPV, and cancer antigen 125 (CA125), alone or in combination, in the diagnosis of endometrial cancer and endometrial hyperplasia. Methods: This study included 144 patients with endometrial cancer (stage I: 32; II: 42; III: 48; and IV: 22), 104 patients with endometrial hyperplasia, and 80 healthy control subjects. The whole blood cell parameters were analyzed by a Mindray Blood Cell Analyzer (CAL8000), whereas CA125 was analyzed using an Architect i2000 Analyzer (Abbott). Results: Significant differences in RDW, MPV, and CA125 level were observed in the endometrial cancer, endometrial hyperplasia, and control groups ( P < .05). Red cell distribution width was positively correlated ( r = .735) whereas MPV was negatively correlated with ( r = −.736) endometrial cancer staging. The area under the receiver operating characteristic curve of the combined diagnosis of endometrial cancer based on RDW, MPV, and CA125 was 0.924 (95% CI: 0.881‐0.955). The sensitivity and specificity of the combined diagnosis were larger than those of the independent detections involving RDW, MPV, and CA125. Conclusions: The combination of RDW, MPV, and CA125 can improve the differential diagnosis of endometrial cancer and endometrial hyperplasia.